Introduction Cancer remains one of the most complex and urgent challenges in modern medicine. While scientific breakthroughs in genomics, targeted therapies, and immunotherapy have dramatically expanded treatment possibilities, the traditional clinical trial framework  has not always kept pace with these advances. Conventional randomised controlled trials (RCTs) are designed with fixed protocols : the sample size, treatment arms, and statistical analysis plans are determined